These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 32020874
1. Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats. Song D, Yin L, Wang C, Wen X. BMC Complement Med Ther; 2020 Jan 31; 20(1):27. PubMed ID: 32020874 [Abstract] [Full Text] [Related]
2. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1]. Zheng H, Hong SC, Yu J, Wen XY. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul 31; 34(7):846-52. PubMed ID: 25137852 [Abstract] [Full Text] [Related]
7. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N, Jia X. J Ethnopharmacol; 2012 Jun 26; 142(1):144-50. PubMed ID: 22564814 [Abstract] [Full Text] [Related]
10. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway. Xu XH, Hu Q, Zhou LS, Xu LJ, Zou X, Lu FE, Yi P. Curr Med Sci; 2020 Jun 26; 40(3):530-538. PubMed ID: 32681256 [Abstract] [Full Text] [Related]
13. Tangganjian decoction ameliorates type 2 diabetes mellitus and nonalcoholic fatty liver disease in rats by activating the IRS/PI3K/AKT signaling pathway. Fan Y, He Z, Wang W, Li J, Hu A, Li L, Yan L, Li Z, Yin Q. Biomed Pharmacother; 2018 Oct 26; 106():733-737. PubMed ID: 29990865 [Abstract] [Full Text] [Related]
14. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. Wang H, Tan H, Zhan W, Song L, Zhang D, Chen X, Lin Z, Wang W, Yang Y, Wang L, Bei W, Guo J. J Ethnopharmacol; 2021 Jun 28; 274():114056. PubMed ID: 33771638 [Abstract] [Full Text] [Related]
15. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease. Ma H, Cui F, Dong JJ, You GP, Yang XJ, Lu HD, Huang YL. World J Gastroenterol; 2014 Oct 28; 20(40):14950-7. PubMed ID: 25356056 [Abstract] [Full Text] [Related]
16. [Modulative effect of zhenqing recipe on expressions of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in experimental type 2 diabetic rats]. Zheng LY, Wen XY, Xu MW. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jun 28; 26 Suppl():72-6. PubMed ID: 17569353 [Abstract] [Full Text] [Related]
17. Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats. Zou W, Zhang C, Gu X, Li X, Zhu H. Drug Des Devel Ther; 2021 Jun 28; 15():2565-2576. PubMed ID: 34168429 [Abstract] [Full Text] [Related]
18. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway. Ramadan NM, Elmasry K, Elsayed HRH, El-Mesery A, Eraky SM. Life Sci; 2022 Dec 15; 311(Pt A):121145. PubMed ID: 36336129 [Abstract] [Full Text] [Related]
20. The adrenergic-regulated CRTC1 and CRTC2 phosphorylation and cellular distribution is independent of endogenous SIK1 in the male rat pinealocyte. McTague J, Ferguson M, Chik CL, Ho AK. Mol Cell Endocrinol; 2015 Oct 15; 414():156-67. PubMed ID: 26210066 [Abstract] [Full Text] [Related] Page: [Next] [New Search]